These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. [Hyperglycemia and ketoacidosis associated with olanzapine]. Von Hayek D; Hüttl V; Reiss J; Schweiger HD; Füessl HS Nervenarzt; 1999 Sep; 70(9):836-7. PubMed ID: 10522253 [TBL] [Abstract][Full Text] [Related]
13. Should lipids be monitored during the first year of treatment with an atypical antipsychotic? Landry P; Benaliouad F Can J Psychiatry; 2003 Jun; 48(5):348-9. PubMed ID: 12866344 [No Abstract] [Full Text] [Related]
14. Olanzapine-induced destabilization of diabetes in the absence of weight gain. Ramankutty G Acta Psychiatr Scand; 2002 Mar; 105(3):235-6; discussion 236-7. PubMed ID: 11939979 [TBL] [Abstract][Full Text] [Related]
15. Weight gain and hyperglycaemia associated with olanzapine. Riccitelli G; Baker N Aust N Z J Psychiatry; 2002 Apr; 36(2):270-1. PubMed ID: 11982558 [No Abstract] [Full Text] [Related]
16. Olanzapine-associated severe hyperglycemia, ketonuria, and acidosis: case report and review of literature. Seaburg HL; McLendon BM; Doraiswamy PM Pharmacotherapy; 2001 Nov; 21(11):1448-54. PubMed ID: 11714220 [TBL] [Abstract][Full Text] [Related]